JP2001523258A - 更年期症状および骨粗鬆症の治療または予防 - Google Patents
更年期症状および骨粗鬆症の治療または予防Info
- Publication number
- JP2001523258A JP2001523258A JP54753598A JP54753598A JP2001523258A JP 2001523258 A JP2001523258 A JP 2001523258A JP 54753598 A JP54753598 A JP 54753598A JP 54753598 A JP54753598 A JP 54753598A JP 2001523258 A JP2001523258 A JP 2001523258A
- Authority
- JP
- Japan
- Prior art keywords
- daidzein
- formononetin
- isoflavone
- treatment
- osteoporosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.更年期症状または骨粗鬆症の治療を必要とする人に治療有効量のイソフラ ボンホルモノネチンを投与する治療または予防方法と、更年期症状または骨粗鬆 症の治療を必要とする人に治療有効量のイソフラボンダイゼインを投与する治療 または予防方法であって、当該イソフラボンを任意に薬学的に許容される1以上 のアジュバント、キャリヤおよび/または賦形剤とともに投与する、更年期症状 または骨粗鬆症の治療または予防方法。 2.骨粗鬆症の治療または予防のための請求項1記載の方法。 3.ホルモノネチンを患者に投与する請求項2記載の方法。 4.更年期症状の治療または予防のための請求項1記載の方法。 5.ホルモノネチンまたはダイゼインを患者に投与する請求項4記載の方法。 6.当該イソフラボンの量がその他すべてのイソフラボン類に比して少なくと も90%(w/w)存在する請求項1記載の方法。 7.当該イソフラボンを少なくとも1日1回投与する請求項1記載の方法。 8.当該イソフラボンを約5mg/日から約400mg/日の量を投与する請 求項1記載の方法。 9.当該イソフラボンが日量約5mgから約400mgとなるように24時間 の間に1回から6回投与する請求項1記載の方法。 10.前記イソフラボンが植物抽出物由来のもので、ダイゼインおよび/また はホルモノネチンを包含し、その他のイソフラボン類を実質的に伴わないもので ある請求項1記載の方法。 11.ホルモノネチンとダイゼインの組み合せ物を患者に投与する骨粗鬆症の 治療または予防のための請求項1記載の方法。 12.当該イソフラボン類が実質的にその他のイソフラボン類を伴わないもの である請求項1記載の方法。 13.ダイゼインを、エクオール、O−デスメチルアンゴレンシ ン(ODMA)、デヒドロエクオール、2−デヒドロ−ODMA、6−ヒドロキ シ−ODMA、ジヒドロダイゼインおよびテトラ−ヒドロダイゼインから選ばれ るダイゼイン代謝物と置き換える請求項1記載の方法。 14.更年期症状の治療または予防のための薬学的組成物であって該組成物が イソフラボンホルモノネチンを、または更年期症状の治療または予防のための薬 学的組成物であって該組成物がイソフラボンダイゼインを、薬学的に許容される 1以上のアジュバント、キャリヤおよび/または賦形剤とともに包含する薬学的 組成物。 15.組成物が骨粗鬆症の治療または予防のための組成物である請求項14記 載の組成物。 16.組成物がイソフラボンホルモノネチンを包含する請求項15記載の組成 物。 17.組成物が急性更年期症状の治療および/または予防のためのものである 請求項14記載の組成物。 18.イソフラボンがダイゼインまたはホルモノネチンである請求項17記載 の組成物。 19.ダイゼインとホルモノネチンの組み合せを包含する請求項17記載の組 成物。 20.5から400mgのイソフラボンを包含する請求項14記載の組成物。 21.ダイゼインが、エクオール、O−デスメチルアンゴレンシン(ODMA )、デヒドロエクオール、2−デヒドロ−ODMA、6−ヒドロキシ−ODMA 、ジヒドロダイゼインおよびテトラ−ヒドロダイゼインから選ばれるダイゼイン 代謝物と置き換えられる請求項14記載の組成物。 22.更年期症状または骨粗鬆症の治療または予防におけるイソフラボンホル モノネチンの使用、または更年期症状の治療または予防におけるイソフラボンダ イゼインの使用であって、当該イソフラボンを任意に薬学的に許容される1以上 のアジュバント、キャリヤ および/または賦形剤とともに投与する使用。 23.約5mgから約400mgの量の当該イソフラボンを投与する請求項2 2記載の使用。 24.当該イソフラボンがホルモノネチンである骨粗鬆症の治療のための請求 項22記載の使用。 25.当該イソフラボンがホルモノネチンまたはダイゼインである更年期症状 の治療のための請求項22記載の使用法。 26.ダイゼインとホルモノネチンの組み合せを患者に投与する請求項25記 載の使用法。 27.更年期症状または骨粗鬆症の治療または予防のための医薬を製造するた めのホルモノネチンの使用法、または骨粗鬆症の治療または予防のための医薬を 製造するためのダイゼインまたはホルモノネチンの使用法。 28.ダイゼインとホルモノネチンを日量約5mgから約400mgとなるよ うに、24時間の間に1回から6回投与する請求項22記載の使用法。 29.イソフラボンダイゼインをホルモノネチンと組み合わせる請求項27記 載の使用法。 30.任意に薬学的に許容される1以上のアジュバント、キャリヤおよび/ま たは賦形剤とともに、フォルモノネチンを包含する更年期症状または骨粗鬆症の 治療またはダイゼイン包含する更年期症状または骨粗鬆症の治療または予防のた めの薬剤。 31.イソフラボンダイゼインが、アグリコン、グリコシド、マロニルまたは アセチル型である請求項1または14記載の方法または組成物。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPO6568A AUPO656897A0 (en) | 1997-05-01 | 1997-05-01 | Treatment and/or prevention of menopausal symptoms and osteoporosis |
AU6568 | 1997-12-08 | ||
AUPP0814A AUPP081497A0 (en) | 1997-12-08 | 1997-12-08 | Treatment and/or prevention of menopausal symptoms and osteoporosis II |
AU0814 | 1997-12-08 | ||
PCT/AU1998/000313 WO1998050026A1 (en) | 1997-05-01 | 1998-05-01 | Treatment or prevention of menopausal symptoms and osteoporosis |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007269270A Division JP2008024723A (ja) | 1997-05-01 | 2007-10-16 | 更年期症状および骨粗鬆症の治療または予防 |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2001523258A true JP2001523258A (ja) | 2001-11-20 |
Family
ID=25645414
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP54753598A Pending JP2001523258A (ja) | 1997-05-01 | 1998-05-01 | 更年期症状および骨粗鬆症の治療または予防 |
JP2007269270A Pending JP2008024723A (ja) | 1997-05-01 | 2007-10-16 | 更年期症状および骨粗鬆症の治療または予防 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007269270A Pending JP2008024723A (ja) | 1997-05-01 | 2007-10-16 | 更年期症状および骨粗鬆症の治療または予防 |
Country Status (6)
Country | Link |
---|---|
US (3) | US6340703B1 (ja) |
EP (1) | EP0979074A4 (ja) |
JP (2) | JP2001523258A (ja) |
CA (1) | CA2287965C (ja) |
NZ (1) | NZ527735A (ja) |
WO (1) | WO1998050026A1 (ja) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005220100A (ja) * | 2004-02-06 | 2005-08-18 | Maruzen Pharmaceut Co Ltd | 抗老化剤、血小板凝集抑制剤、抗酸化剤、抗アレルギー剤、皮膚化粧料及び飲食品 |
JP2005232074A (ja) * | 2004-02-19 | 2005-09-02 | Tokyo Univ Of Agriculture | 骨粗鬆症の予防及び/又は治療剤 |
WO2006035897A1 (ja) * | 2004-09-30 | 2006-04-06 | Fuji Oil Company, Limited | 性ホルモン結合グロブリン阻害組成物 |
WO2008126752A1 (ja) | 2007-04-09 | 2008-10-23 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | エクオール類を有効成分とする美白剤 |
JP2009536610A (ja) * | 2006-02-28 | 2009-10-15 | カウンシル オブ サイエンティフィク アンド インダストリアル リサーチ | 骨疾患の予防/治療のための医薬組成物及びその調製方法 |
JP2009545605A (ja) * | 2006-08-02 | 2009-12-24 | ユニバーシティ オブ サザン カリフォルニア | フィトエストロゲン製剤およびその使用 |
US8552057B2 (en) | 2006-08-02 | 2013-10-08 | University Of Southern California | Phytoestrogenic formulations for alleviation or prevention of neurodegenerative diseases |
US8680140B2 (en) | 2006-08-02 | 2014-03-25 | University Of Southern California | Phytoestrogenic formulations for alleviation or prevention of menopausal symptoms |
JP2016196430A (ja) * | 2015-04-03 | 2016-11-24 | 株式会社ダイセル | エクオール及び保湿剤を含有する外用組成物 |
JP2016196427A (ja) * | 2015-04-03 | 2016-11-24 | 株式会社ダイセル | エクオール、酸化防止剤、及び油類を含有する外用組成物 |
JP2016196428A (ja) * | 2015-04-03 | 2016-11-24 | 株式会社ダイセル | エクオール及びキレート剤を含有する外用組成物 |
Families Citing this family (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT656786E (pt) * | 1992-05-19 | 2004-11-30 | Novogen Res Pty Ltd | Utilizacao de extractos do fitoestrogenio isoflavona de soja ou trevo |
AUPO203996A0 (en) | 1996-08-30 | 1996-09-26 | Novogen Research Pty Ltd | Therapeutic uses |
US6146668A (en) | 1997-04-28 | 2000-11-14 | Novogen, Inc. | Preparation of isoflavones from legumes |
AUPP112497A0 (en) * | 1997-12-24 | 1998-01-22 | Novogen Research Pty Ltd | Compositions and method for protecting skin from UV induced immunosupression and skin damage |
US20050037100A1 (en) * | 1998-03-19 | 2005-02-17 | Bionorica Ag | Utilization of extracts from iris plants, cimicifuga racemose and tectorigenin as an estrogen-like organ-selective medicament without uterotropic |
AUPP260798A0 (en) | 1998-03-26 | 1998-04-23 | Novogen Research Pty Ltd | Treatment of medical related conditions with isoflavone containing extracts of clover |
IL145839A0 (en) * | 1999-04-16 | 2002-07-25 | Astrazeneca Ab | ESTROGEN RECEPTOR-β LIGANDS |
AUPQ008399A0 (en) * | 1999-04-28 | 1999-05-27 | Novogen Research Pty Ltd | Cariovascular applications |
AU761047B2 (en) * | 1999-04-28 | 2003-05-29 | Novogen Research Pty Ltd | Cardiovascular and bone treatment using isoflavones |
AUPQ008299A0 (en) | 1999-04-30 | 1999-05-27 | G.J. Consultants Pty Ltd | Isoflavone metabolites |
US20090233999A1 (en) * | 1999-09-06 | 2009-09-17 | Novogen Research Pty Ltd | Compositions and therapeutic methods involving isoflavones and analogues thereof |
AUPQ266199A0 (en) * | 1999-09-06 | 1999-09-30 | Novogen Research Pty Ltd | Compositions and therapeutic methods involving isoflavones and analogues thereof |
AUPQ520300A0 (en) * | 2000-01-21 | 2000-02-17 | Novogen Research Pty Ltd | Food product and process |
EP1132084A1 (en) * | 2000-03-06 | 2001-09-12 | Docteur Nature Srl | Transdermal device for the slow release of soybean derived vegetable estrogens |
US6777450B1 (en) | 2000-05-26 | 2004-08-17 | Color Access, Inc. | Water-thin emulsions with low emulsifier levels |
AU2001296119A1 (en) * | 2000-10-13 | 2002-04-22 | Astrazeneca Ab | Estrogen receptor-beta ligands |
US8501245B2 (en) * | 2000-12-05 | 2013-08-06 | Morinda, Inc. | Selectively inhibiting estrogen production and providing estrogenic effects in the human body |
AUPR255401A0 (en) * | 2001-01-16 | 2001-02-08 | Novogen Research Pty Ltd | Regulation of lipids and/or bone density and compositions therefor |
AUPR363301A0 (en) | 2001-03-08 | 2001-04-05 | Novogen Research Pty Ltd | Dimeric isoflavones |
US20050119301A1 (en) * | 2001-03-16 | 2005-06-02 | Alan Husband | Treatment of restenosis |
PT1379146E (pt) * | 2001-03-23 | 2009-09-02 | Nutricia Nv | Preparação para a prevenção da alteração do metabolismo ósseo |
AUPR846401A0 (en) * | 2001-10-25 | 2001-11-15 | Novogen Research Pty Ltd | 6-Hydroxy isoflavones, derivatives and medicaments involving same |
DE10206390A1 (de) * | 2002-02-15 | 2003-08-28 | Bionorica Ag | Verwendung von selektiv den Estrogenrezeptor beta modulierenden phytoestrogenhaltigen Extrakten |
EP1503751A4 (en) * | 2002-04-09 | 2007-08-01 | Novogen Res Pty Ltd | THERAPEUTIC PROCESSES AND COMPOSITIONS WITH ISOFLAV-3-EN AND ISOFLAVAN STRUCTURES |
FR2841472B1 (fr) * | 2002-06-28 | 2006-02-24 | Agronomique Inst Nat Rech | Composition nutritionnelle ou therapeutique contenant le compose hesperidine ou l'un de ses derives |
WO2004039327A2 (en) * | 2002-10-29 | 2004-05-13 | Colorado State University Research Foundation | Use of equol for treating androgen mediated diseases |
US8668914B2 (en) * | 2002-07-24 | 2014-03-11 | Brigham Young University | Use of equol for treating skin diseases |
WO2004009035A2 (en) | 2002-07-24 | 2004-01-29 | Children's Hospital Medical Center | Compositions and products containing enantiomeric equol, and methods for their making |
US7271209B2 (en) * | 2002-08-12 | 2007-09-18 | Exxonmobil Chemical Patents Inc. | Fibers and nonwovens from plasticized polyolefin compositions |
US7998579B2 (en) * | 2002-08-12 | 2011-08-16 | Exxonmobil Chemical Patents Inc. | Polypropylene based fibers and nonwovens |
US7531594B2 (en) * | 2002-08-12 | 2009-05-12 | Exxonmobil Chemical Patents Inc. | Articles from plasticized polyolefin compositions |
US8003725B2 (en) * | 2002-08-12 | 2011-08-23 | Exxonmobil Chemical Patents Inc. | Plasticized hetero-phase polyolefin blends |
CA2492839C (en) * | 2002-08-12 | 2011-02-01 | Exxonmobil Chemical Patents Inc. | Plasticized polyolefin compositions |
US7018986B2 (en) * | 2002-09-20 | 2006-03-28 | Immudyne | Use of beta glucans for the treatment of osteoporosis and other diseases of bone resorption |
US7700707B2 (en) | 2002-10-15 | 2010-04-20 | Exxonmobil Chemical Patents Inc. | Polyolefin adhesive compositions and articles made therefrom |
US7541402B2 (en) * | 2002-10-15 | 2009-06-02 | Exxonmobil Chemical Patents Inc. | Blend functionalized polyolefin adhesive |
US7223822B2 (en) | 2002-10-15 | 2007-05-29 | Exxonmobil Chemical Patents Inc. | Multiple catalyst and reactor system for olefin polymerization and polymers produced therefrom |
US7550528B2 (en) * | 2002-10-15 | 2009-06-23 | Exxonmobil Chemical Patents Inc. | Functionalized olefin polymers |
CN101724110B (zh) * | 2002-10-15 | 2013-03-27 | 埃克森美孚化学专利公司 | 用于烯烃聚合的多催化剂体系和由其生产的聚合物 |
US8580846B2 (en) | 2002-10-29 | 2013-11-12 | Brigham Young University | Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders |
WO2004084818A2 (en) * | 2003-03-21 | 2004-10-07 | The Regents Of The University Of California | Measurement of estrogen activity in plants and a composition therefrom |
US8192813B2 (en) | 2003-08-12 | 2012-06-05 | Exxonmobil Chemical Patents, Inc. | Crosslinked polyethylene articles and processes to produce same |
US20050107350A1 (en) * | 2003-08-22 | 2005-05-19 | Pharmacia Corporation | Method for the treatment or prevention of bone disorders with a cyclooxygenase-2 inhibitor alone and in combination with a bone disorder treatment agent and compositions therewith |
US7645829B2 (en) * | 2004-04-15 | 2010-01-12 | Exxonmobil Chemical Patents Inc. | Plasticized functionalized propylene copolymer adhesive composition |
EP1740191A4 (en) * | 2004-04-28 | 2008-07-30 | Univ Brigham Young | USE OF EQUOL FOR THE TREATMENT OF SKIN DISEASES |
US8663679B2 (en) | 2004-04-29 | 2014-03-04 | Abbott Laboratories | Compositions for improving breast health in women |
US8377484B1 (en) * | 2004-05-06 | 2013-02-19 | Maria V. Tsiper | Tumor encapsulation for prevention and treatment of metastatic cancer disease |
EP1600061B1 (en) * | 2004-05-25 | 2010-05-12 | Cognis IP Management GmbH | Oral and/or topical compositions |
US7435431B2 (en) * | 2004-07-28 | 2008-10-14 | Abbott Laboratories | Method for controlling body weight in estrogen-insufficient women |
US20060040001A1 (en) * | 2004-07-28 | 2006-02-23 | Johnson Catherine D | Nutritional compositions and methods for treating or preventing osteoporosis |
US7601370B2 (en) * | 2004-07-28 | 2009-10-13 | Abbott Laboratories | Method for controlling body weight in estrogen-insufficient women |
US8389615B2 (en) | 2004-12-17 | 2013-03-05 | Exxonmobil Chemical Patents Inc. | Elastomeric compositions comprising vinylaromatic block copolymer, polypropylene, plastomer, and low molecular weight polyolefin |
US9745461B2 (en) | 2005-06-22 | 2017-08-29 | Exxonmobil Chemical Patents Inc. | Vulcanized polymer blends |
US7928164B2 (en) * | 2005-06-22 | 2011-04-19 | Exxonmobil Chemical Patents Inc. | Homogeneous polymer blend and process of making the same |
US20060293462A1 (en) * | 2005-06-22 | 2006-12-28 | Sunny Jacob | Heterogeneous polymer blend and process of making the same |
US9644092B2 (en) | 2005-06-22 | 2017-05-09 | Exxonmobil Chemical Patents Inc. | Heterogeneous in-situ polymer blend |
US7951872B2 (en) * | 2005-06-22 | 2011-05-31 | Exxonmobil Chemical Patents Inc. | Heterogeneous polymer blend with continuous elastomeric phase and process of making the same |
CN101218296B (zh) | 2005-07-15 | 2010-12-08 | 埃克森美孚化学专利公司 | 弹性体组合物 |
EP2197297A1 (en) * | 2007-10-17 | 2010-06-23 | Unilever N.V. | Encapsultated omega-3 fatty acids and/or omega-6 fatty acids and/or esters thereof with a coating |
US8399725B2 (en) * | 2008-06-20 | 2013-03-19 | Exxonmobil Chemical Patents Inc. | Functionalized high vinyl terminated propylene based oligomers |
US8372930B2 (en) * | 2008-06-20 | 2013-02-12 | Exxonmobil Chemical Patents Inc. | High vinyl terminated propylene based oligomers |
US8283419B2 (en) * | 2008-06-20 | 2012-10-09 | Exxonmobil Chemical Patents Inc. | Olefin functionalization by metathesis reaction |
US20100267661A1 (en) * | 2009-03-17 | 2010-10-21 | Immudyne, Inc. | Beta glucans and methods of use thereof |
US10307451B2 (en) | 2010-02-15 | 2019-06-04 | Sinoveda Canada Inc. | Phytoestrogen product of red clover and pharmaceutical uses thereof |
US9333192B2 (en) | 2010-02-15 | 2016-05-10 | Sinoveda Canada, Inc | Phytoestrogen product of red clover and pharmaceutical uses thereof |
KR101307947B1 (ko) | 2011-11-30 | 2013-09-12 | 씨제이제일제당 (주) | 싸이코스를 유효성분으로 하는 에쿠올 농도 상승제 |
US9044476B2 (en) | 2013-01-16 | 2015-06-02 | Taipei Medical University | Use of uraria in promoting osteogenesis or providing neuroprotection |
FR3005419B1 (fr) | 2013-05-13 | 2015-09-04 | Agronomique Inst Nat Rech | Utilisation d'une association de deux composes pour le traitement et/ou la prevention de troubles osseux |
FR3066919B1 (fr) | 2017-06-06 | 2019-08-02 | Institut National De La Recherche Agronomique (Inra) | Composition de phycocyanine pour son utilisation pour inhiber la resorption osseuse. |
Family Cites Families (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1518002C3 (de) * | 1965-01-02 | 1975-01-23 | Merck Patent Gmbh, 6100 Darmstadt | Isoflavane und Isoflavene und Verfahren zu Ihrer Herstellung sowie diese enthaltende Arzneimittel |
DE1543749A1 (de) * | 1966-02-16 | 1969-12-11 | Merck Ag E | Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen |
US3973608A (en) * | 1973-08-01 | 1976-08-10 | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | Microbial production of certain isoflavones |
DE2643800C2 (de) * | 1976-09-29 | 1986-10-30 | Fritz Werner Industrie-Ausrüstungen GmbH, 6222 Geisenheim | Verfahren zur Herstellung von Xylose durch enzymatische Hydrolyse von Xylanen |
US4264509A (en) * | 1977-06-08 | 1981-04-28 | Z-L Limited Partnership | Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same |
US4157984A (en) * | 1977-06-08 | 1979-06-12 | Z-L Limited | Antioxidants, antioxidant compositions and methods of preparing and using same |
SU907060A1 (ru) * | 1979-02-07 | 1982-02-23 | Всесоюзный Научно-Исследовательский Биотехнический Институт | Способ получени розового масла |
US4366082A (en) * | 1979-04-11 | 1982-12-28 | Z-L Limited Partnership | Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same |
US4390559A (en) | 1979-04-11 | 1983-06-28 | Z-L Limited Partnership | Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same |
US4379177A (en) * | 1979-07-05 | 1983-04-05 | The Procter & Gamble Company | Stable dehydrated cocrystalline amino acid food additives |
JPS5933232A (ja) * | 1982-08-19 | 1984-02-23 | Tokiwa Kanpou Seiyaku:Kk | マメ科植物からサポニン類およびフラボン類の分離方法 |
JPS6048924A (ja) * | 1983-08-24 | 1985-03-16 | Takeda Chem Ind Ltd | 骨粗鬆症治療剤 |
JPS61246124A (ja) | 1985-04-24 | 1986-11-01 | Yamanouchi Pharmaceut Co Ltd | 制癌剤 |
JPS62126186A (ja) | 1985-11-28 | 1987-06-08 | Tsumura Juntendo Inc | イソフラボン誘導体含有溶液の製造方法 |
GB8626344D0 (en) * | 1986-11-04 | 1986-12-03 | Zyma Sa | Bicyclic compounds |
JPH0714927B2 (ja) | 1988-04-06 | 1995-02-22 | キッコーマン株式会社 | イソフラボン化合物の製造法 |
JPH0269165A (ja) | 1988-09-02 | 1990-03-08 | Mitsugi Ohashi | 癌抑制食品 |
JPH0347049A (ja) | 1989-03-09 | 1991-02-28 | Sanyu:Kk | 豆腐廃液ゆからの食品素材及び健康飲料の製造方法 |
US5153230A (en) * | 1989-10-06 | 1992-10-06 | Perfective Cosmetics, Inc. | Topical skin cream composition |
CH679584A5 (ja) | 1989-11-10 | 1992-03-13 | Nestle Sa | |
JPH089610B2 (ja) * | 1990-04-06 | 1996-01-31 | キノイン・ジョージセル・エーシュ・ヴェジェーセティ・テルメーケク・ジャーラ・エルテー | 置換イソフラボン誘導体の改良された製造方法 |
GB2261671B (en) * | 1991-11-16 | 1996-07-03 | Gb Biotech | Gel production from plant matter |
PT656786E (pt) * | 1992-05-19 | 2004-11-30 | Novogen Res Pty Ltd | Utilizacao de extractos do fitoestrogenio isoflavona de soja ou trevo |
AU6635994A (en) | 1993-04-16 | 1994-11-08 | Tufts University School Of Medicine | Method for treatment of menopausal and premenstrual symptoms |
DE69429931T3 (de) * | 1993-10-12 | 2006-12-21 | Archer Daniels Midland Co., Decatur | Aglucon-isoflavon-angereicherter pflanzicher proteinextrakt, isolat und herstellungsprozess |
US5320949A (en) * | 1993-10-12 | 1994-06-14 | Protein Technologies International, Inc. | Process for producing aglucone isoflavone enriched vegetable protein fiber |
JP3787844B2 (ja) * | 1993-10-12 | 2006-06-21 | アーチャー ダニエルズ ミッドランド カンパニー | アグルコンイソフラボン濃縮植物タンパク質乳漿,乳漿タンパク質,及びその製造方法 |
IL112061A (en) * | 1994-01-13 | 1999-10-28 | Bristol Myers Squibb Co | Methods for the preparation of taxanes |
US5506211A (en) * | 1994-05-09 | 1996-04-09 | The Uab Research Foundation | Genistein for use in inhibiting osteroclasts |
US5424331A (en) * | 1994-06-10 | 1995-06-13 | Bio-Virus Research Incorporated | Pharmaceutical compositions and dietary soybean food products for the prevention of osteoporosis |
US5547866A (en) * | 1994-07-20 | 1996-08-20 | The Regents Of The University Of California | Taxane production in haploid-derived cell cultures |
US5637598A (en) * | 1994-11-18 | 1997-06-10 | Eli Lilly And Company | Methods of inhibiting bone loss |
US5516528A (en) * | 1995-01-13 | 1996-05-14 | Wake Forest University | Dietary phytoestrogen in estrogen replacement therapy |
US5569459A (en) * | 1995-02-15 | 1996-10-29 | Bio-Virus Research Incorporated | Pharmaceutical compositions for the management of premenstrual syndrome and alleviation of menopausal disorders |
US5523087A (en) * | 1995-02-15 | 1996-06-04 | Bio-Virus Research Incorporated | Pharmaceutical compositions for the treatment of diabetic male sexual dysfunction |
US5679806A (en) * | 1995-02-24 | 1997-10-21 | Hauser, Inc. | Process for the isolation and purification of isoflavones |
JPH08283283A (ja) * | 1995-04-14 | 1996-10-29 | Kikkoman Corp | マロニルイソフラボン配糖体及び該物質からイソフラボン配糖体又はイソフラボンアグリコンを取得する方法 |
US5639785A (en) * | 1995-06-07 | 1997-06-17 | Global Pharma, Ltd. | Methods for the treatment of baldness and gray hair using isoflavonoid derivatives |
US5554519A (en) * | 1995-08-07 | 1996-09-10 | Fermalogic, Inc. | Process of preparing genistein |
US6261565B1 (en) * | 1996-03-13 | 2001-07-17 | Archer Daniels Midland Company | Method of preparing and using isoflavones |
US6033714A (en) * | 1996-03-13 | 2000-03-07 | Archer Daniels Midland Company | Process for production of isoflavone fractions from soy |
US5702752A (en) * | 1996-03-13 | 1997-12-30 | Archer Daniels Midland Company | Production of isoflavone enriched fractions from soy protein extracts |
US5821361A (en) | 1996-06-11 | 1998-10-13 | Protein Technologies International, Inc. | Recovery of isoflavones from soy molasses |
CA2261764A1 (en) * | 1996-07-30 | 1998-02-05 | Jeffrey B. Blumberg | Dietary supplements |
AUPO203996A0 (en) * | 1996-08-30 | 1996-09-26 | Novogen Research Pty Ltd | Therapeutic uses |
US5726034A (en) * | 1996-09-06 | 1998-03-10 | Protein Technologies International, Inc. | Aglucone isoflavone enriched vegetable protein extract and protein material, and high genistein and daidzein content materials and process for producing the same |
US5804234A (en) * | 1996-09-13 | 1998-09-08 | Suh; John D. | Plant protein for nutritional products and method of making same |
AU5260698A (en) * | 1996-11-18 | 1998-06-10 | Internutria, Inc. | Composition and treatment for persistent reproductive transition symptoms |
US5733926A (en) * | 1996-12-13 | 1998-03-31 | Gorbach; Sherwood L. | Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions |
US6146668A (en) * | 1997-04-28 | 2000-11-14 | Novogen, Inc. | Preparation of isoflavones from legumes |
US6060070A (en) * | 1997-06-11 | 2000-05-09 | Gorbach; Sherwood L. | Isoflavonoids for treatment and prevention of aging skin and wrinkles |
US5855892A (en) * | 1997-09-19 | 1999-01-05 | Potter; Susan M. | Method for decreasing LDL-cholesterol concentration and increasing HDL-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease |
US5942539A (en) * | 1997-10-03 | 1999-08-24 | Wake Forest University | Methods of treating or preventing endometriosis with phytoestrogens |
AUPP112497A0 (en) * | 1997-12-24 | 1998-01-22 | Novogen Research Pty Ltd | Compositions and method for protecting skin from UV induced immunosupression and skin damage |
US6004558A (en) * | 1998-02-25 | 1999-12-21 | Novogen, Inc. | Methods for treating cancer with legume plant extracts |
JP2002506806A (ja) * | 1998-03-16 | 2002-03-05 | ザ、プロクター、エンド、ギャンブル、カンパニー | 皮膚の外観を調節する組成物 |
AUPP260798A0 (en) * | 1998-03-26 | 1998-04-23 | Novogen Research Pty Ltd | Treatment of medical related conditions with isoflavone containing extracts of clover |
AUPP868599A0 (en) * | 1999-02-15 | 1999-03-11 | Novogen Research Pty Ltd | Production of isoflavone derivatives |
US20040072765A1 (en) * | 1999-04-28 | 2004-04-15 | Novogen Research Pty Ltd. | Cardiovascular and bone treatment using isoflavones |
AUPQ266199A0 (en) * | 1999-09-06 | 1999-09-30 | Novogen Research Pty Ltd | Compositions and therapeutic methods involving isoflavones and analogues thereof |
AUPQ520300A0 (en) * | 2000-01-21 | 2000-02-17 | Novogen Research Pty Ltd | Food product and process |
AUPR255401A0 (en) * | 2001-01-16 | 2001-02-08 | Novogen Research Pty Ltd | Regulation of lipids and/or bone density and compositions therefor |
AUPR363301A0 (en) * | 2001-03-08 | 2001-04-05 | Novogen Research Pty Ltd | Dimeric isoflavones |
-
1998
- 1998-05-01 JP JP54753598A patent/JP2001523258A/ja active Pending
- 1998-05-01 US US09/077,590 patent/US6340703B1/en not_active Expired - Fee Related
- 1998-05-01 EP EP98916669A patent/EP0979074A4/en not_active Withdrawn
- 1998-05-01 WO PCT/AU1998/000313 patent/WO1998050026A1/en not_active Application Discontinuation
- 1998-05-01 CA CA002287965A patent/CA2287965C/en not_active Expired - Fee Related
- 1998-05-01 NZ NZ527735A patent/NZ527735A/en not_active IP Right Cessation
-
2001
- 2001-11-09 US US09/986,509 patent/US20020035074A1/en not_active Abandoned
-
2007
- 2007-10-16 JP JP2007269270A patent/JP2008024723A/ja active Pending
-
2011
- 2011-06-23 US US13/167,439 patent/US20110312906A1/en not_active Abandoned
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005220100A (ja) * | 2004-02-06 | 2005-08-18 | Maruzen Pharmaceut Co Ltd | 抗老化剤、血小板凝集抑制剤、抗酸化剤、抗アレルギー剤、皮膚化粧料及び飲食品 |
JP4672269B2 (ja) * | 2004-02-06 | 2011-04-20 | 丸善製薬株式会社 | 抗老化剤、血小板凝集抑制剤、抗酸化剤、抗アレルギー剤、皮膚化粧料及び飲食品 |
JP2005232074A (ja) * | 2004-02-19 | 2005-09-02 | Tokyo Univ Of Agriculture | 骨粗鬆症の予防及び/又は治療剤 |
WO2006035897A1 (ja) * | 2004-09-30 | 2006-04-06 | Fuji Oil Company, Limited | 性ホルモン結合グロブリン阻害組成物 |
JP2009536610A (ja) * | 2006-02-28 | 2009-10-15 | カウンシル オブ サイエンティフィク アンド インダストリアル リサーチ | 骨疾患の予防/治療のための医薬組成物及びその調製方法 |
JP2009545605A (ja) * | 2006-08-02 | 2009-12-24 | ユニバーシティ オブ サザン カリフォルニア | フィトエストロゲン製剤およびその使用 |
US8552057B2 (en) | 2006-08-02 | 2013-10-08 | University Of Southern California | Phytoestrogenic formulations for alleviation or prevention of neurodegenerative diseases |
US8680140B2 (en) | 2006-08-02 | 2014-03-25 | University Of Southern California | Phytoestrogenic formulations for alleviation or prevention of menopausal symptoms |
WO2008126752A1 (ja) | 2007-04-09 | 2008-10-23 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | エクオール類を有効成分とする美白剤 |
JP2016196430A (ja) * | 2015-04-03 | 2016-11-24 | 株式会社ダイセル | エクオール及び保湿剤を含有する外用組成物 |
JP2016196427A (ja) * | 2015-04-03 | 2016-11-24 | 株式会社ダイセル | エクオール、酸化防止剤、及び油類を含有する外用組成物 |
JP2016196428A (ja) * | 2015-04-03 | 2016-11-24 | 株式会社ダイセル | エクオール及びキレート剤を含有する外用組成物 |
Also Published As
Publication number | Publication date |
---|---|
WO1998050026A1 (en) | 1998-11-12 |
US20110312906A1 (en) | 2011-12-22 |
NZ527735A (en) | 2005-10-28 |
CA2287965C (en) | 2009-10-20 |
EP0979074A4 (en) | 2003-07-09 |
EP0979074A1 (en) | 2000-02-16 |
JP2008024723A (ja) | 2008-02-07 |
CA2287965A1 (en) | 1998-11-12 |
US20020035074A1 (en) | 2002-03-21 |
US6340703B1 (en) | 2002-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2001523258A (ja) | 更年期症状および骨粗鬆症の治療または予防 | |
US5498631A (en) | Method for treatment of menopausal and premenstrual symptoms | |
US6987098B2 (en) | Health supplement | |
JPH11139973A (ja) | 血中のldl−コレステロール濃度を減少しhdl−コレステロール濃度を増加させ、アテローム硬化症及び道管病の危険性を減少させる方法 | |
WO1999007381A1 (en) | Compositions and treatments to reduce side effects of administration of androgenic testosterone precursors | |
EP1481676B1 (en) | Phytoestrogens and probiotic for women's health | |
WO2004089359A1 (ja) | 骨密度減少の抑制または予防用組成物および飲食品 | |
EP1082122A1 (en) | Isoflavonoids for treatment and prevention of migraine headaches | |
AU779210B2 (en) | Treatments or prevention of menopausal symptoms and osteoporosis | |
JP3250071B2 (ja) | 抗骨粗鬆症組成物 | |
AU7017198A (en) | Treatment or prevention of menopausal symptoms and osteoporosis | |
US20080161385A1 (en) | Composition Inhibiting Sex Hormone-Binding Globulin | |
AU777632B2 (en) | Health supplements containing isoflavones | |
AU2004224983A1 (en) | Health supplements containing isoflavones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060620 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20060919 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20061106 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061220 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070619 |